EU regulator backs J&J shot, finds possible link to clots
Published: Apr 21, 2021 1:42 AM
Europe's drug regulator has found a possible link between Johnson & Johnson's Covid-19 vaccine and rare blood clotting issues in adults who received doses in the United States, but backed its overall benefits against any risks.
The European Medicines Agency (EMA) said on Tuesday its safety committee had concluded that a warning about unusual blood clots with low platelets must be added to the vaccine's labels, just as has also been required of rival shot maker AstraZeneca.
View Comments0
Report this comment
500 characters remaining
Are you sure you want to delete this comment?
This action cannot be undone.